Published in ILAR J on June 01, 1999
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol (2007) 2.01
Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain (2011) 1.87
The endocannabinoid system and pain. CNS Neurol Disord Drug Targets (2009) 1.59
Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity. Immunity (2015) 1.58
Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memory. Neurobiol Learn Mem (2013) 0.98
Expression and function of proton-sensing G-protein-coupled receptors in inflammatory pain. Mol Pain (2009) 0.97
Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner. Pain (2010) 0.91
Behavioral testing in rodent models of orofacial neuropathic and inflammatory pain. Brain Behav (2012) 0.88
Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice. J Zhejiang Univ Sci B (2015) 0.85
Modeling nociception in zebrafish: a way forward for unbiased analgesic discovery. PLoS One (2015) 0.84
Potassium channels in peripheral pain pathways: expression, function and therapeutic potential. Curr Neuropharmacol (2013) 0.84
Alteration of neuronal activity after digit amputation in rat anterior cingulate cortex. Int J Physiol Pathophysiol Pharmacol (2013) 0.80
Voluntary Exercise Training: Analysis of Mice in Uninjured, Inflammatory, and Nerve-Injured Pain States. PLoS One (2015) 0.80
The search for novel analgesics: targets and mechanisms. F1000Prime Rep (2015) 0.79
Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain. Alcohol Alcohol (2014) 0.79
The degree of acute descending control of spinal nociception in an area of primary hyperalgesia is dependent on the peripheral domain of afferent input. J Physiol (2014) 0.79
Social transfer of pain in mice. Sci Adv (2016) 0.78
Changes in response properties of rostral ventromedial medulla neurons during prolonged inflammation: modulation by neurokinin-1 receptors. Neuroscience (2012) 0.78
The Physiology of Bone Pain. How Much Do We Really Know? Front Physiol (2016) 0.78
Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury. J Cell Commun Signal (2015) 0.77
HDAC4 is required for inflammation-associated thermal hypersensitivity. FASEB J (2015) 0.77
Contrasting alterations to synaptic and intrinsic properties in upper-cervical superficial dorsal horn neurons following acute neck muscle inflammation. Mol Pain (2014) 0.76
Neonatal inflammatory pain and systemic inflammatory responses as possible environmental factors in the development of autism spectrum disorder of juvenile rats. J Neuroinflammation (2016) 0.76
IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain. J Neurosci (2016) 0.76
Application of a handheld Pressure Application Measurement device for the characterisation of mechanical nociceptive thresholds in intact pig tails. Physiol Behav (2016) 0.75
Cutaneous tissue damage induces long-lasting nociceptive sensitization and regulation of cellular stress- and nerve injury-associated genes in sensory neurons. Exp Neurol (2016) 0.75
Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model. BMC Complement Altern Med (2017) 0.75
Protective efficacy of N-(2-hydroxyphenyl) acetamide against adjuvant-induced arthritis in rats. Biomed Res Int (2013) 0.75
Anti-inflammatory and anti-hyperalgesic activities of Acanthopanax trifoliatus (L) Merr leaves. Pharmacognosy Res (2013) 0.75
Skin Immunity to Candida albicans. Trends Immunol (2016) 0.75
Peripheral inflammatory pain sensitisation is independent of mast cell activation in male mice. Pain (2017) 0.75
Sleep Deprivation and Recovery Sleep Prior to a Noxious Inflammatory Insult Influence Characteristics and Duration of Pain. Sleep (2016) 0.75
AMPKα1 knockout enhances nociceptive behaviors and spinal glutamatergic synaptic activities via production of reactive oxygen species in the spinal dorsal horn. Neuroscience (2016) 0.75
The imidazoline receptors and ligands in pain modulation. Indian J Pharmacol (2015) 0.75
Acupuncture for chronic low back pain. N Engl J Med (2010) 3.90
Interactions between the immune and nervous systems in pain. Nat Med (2010) 2.91
Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci (2007) 2.44
Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol (2008) 1.99
Descending modulation in persistent pain: an update. Pain (2002) 1.92
Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain (2011) 1.62
Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci (2008) 1.61
Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J Neurosci (2002) 1.55
Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain (2011) 1.50
Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain (2011) 1.48
Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.45
Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. J Neurosci (2006) 1.45
Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci (2010) 1.37
Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia. J Neurosci (2004) 1.35
Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.32
Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain (2010) 1.19
Plasticity in excitatory amino acid receptor-mediated descending pain modulation after inflammation. J Pharmacol Exp Ther (2002) 1.18
Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain (2013) 1.18
Pain facilitation and activity-dependent plasticity in pain modulatory circuitry: role of BDNF-TrkB signaling and NMDA receptors. Mol Neurobiol (2007) 1.14
Study protocol, sample characteristics, and loss to follow-up: the OPPERA prospective cohort study. J Pain (2013) 1.12
General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study. J Pain (2013) 1.11
Trigeminal transition zone/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats. J Comp Neurol (2005) 1.09
Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol Pain (2009) 1.08
Antibody array analysis of peripheral and blood cytokine levels in rats after masseter inflammation. Neurosci Lett (2005) 1.08
Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study. J Pain (2013) 1.08
Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study. J Pain (2013) 1.06
Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study. J Pain (2013) 1.05
Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions. J Pain (2013) 1.04
Clinical orofacial characteristics associated with risk of first-onset TMD: the OPPERA prospective cohort study. J Pain (2013) 1.03
Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models. Pain (2002) 1.01
Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Stem Cells (2011) 0.99
Inflammation-induced upregulation of AMPA receptor subunit expression in brain stem pain modulatory circuitry. Pain (2003) 0.99
Selective distribution and function of primary afferent nociceptive inputs from deep muscle tissue to the brainstem trigeminal transition zone. J Comp Neurol (2006) 0.97
The role of trigeminal interpolaris-caudalis transition zone in persistent orofacial pain. Int Rev Neurobiol (2011) 0.97
Neurons involved in the exteroceptive function of pain. Pain (2003) 0.95
Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain. Mol Pain (2010) 0.93
Changes in AMPA receptor phosphorylation in the rostral ventromedial medulla after inflammatory hyperalgesia in rats. Neurosci Lett (2004) 0.93
Summary of findings from the OPPERA baseline case-control study: implications and future directions. J Pain (2011) 0.92
Multivariable modeling of phenotypic risk factors for first-onset TMD: the OPPERA prospective cohort study. J Pain (2013) 0.90
Transition to persistent orofacial pain after nerve injury involves supraspinal serotonin mechanisms. J Neurosci (2013) 0.89
Trigeminal-rostral ventromedial medulla circuitry is involved in orofacial hyperalgesia contralateral to tissue injury. Mol Pain (2012) 0.89
Neonatal local noxious insult affects gene expression in the spinal dorsal horn of adult rats. Mol Pain (2005) 0.86
Retracted Spinal 5-HT(3) receptor activation induces behavioral hypersensitivity via a neuronal-glial-neuronal signaling cascade. J Neurosci (2011) 0.84
Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats. Open Pain J (2009) 0.83
Differential rostral projections of caudal brainstem neurons receiving trigeminal input after masseter inflammation. J Comp Neurol (2003) 0.83
Identification of clusters of individuals relevant to temporomandibular disorders and other chronic pain conditions: the OPPERA study. Pain (2016) 0.83
Spinal 5-HT3 receptors mediate descending facilitation and contribute to behavioral hypersensitivity via a reciprocal neuron-glial signaling cascade. Mol Pain (2014) 0.82
Activation of group I mGlu receptors contributes to facilitation of NMDA receptor membrane current in spinal dorsal horn neurons after hind paw inflammation in rats. Eur J Pharmacol (2011) 0.81
Modification of COMT-dependent pain sensitivity by psychological stress and sex. Pain (2016) 0.78
Multipotent stromal cells for arthritic joint pain therapy and beyond. Pain Manag (2014) 0.76
Attenuation of pain in a randomized trial by suppression of peripheral nociceptive activity in the immediate postoperative period. Anesth Analg (2002) 0.76
A bibliometric analysis of the Pain journal as a representation of progress and trends in the field. Pain (2009) 0.76
What can be learned by assessing funding patterns for pain research? A commentary on National Institutes of Health grant awards for pain, nausea, and dyspnea research. J Pain (2005) 0.75
Demonstration of a trigeminothalamic pathway to the oval paracentral intralaminar thalamic nucleus and its involvement in the processing of noxious orofacial deep inputs. Brain Res (2006) 0.75
Thanks to Reviewers for 2014 and 2015. Pain (2016) 0.75